Showing results (111-120 of 264) with videos related to

Sort By:
Pageof 27
In Vivo (Athens, Greece)|October 31, 2019
Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell LinesTakashi Miwa, Mitsuro Kanda, Shinichi Umeda, et al.
Annals of Surgical Oncology|December 19, 2019
Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic CancerNobuhiko Nakagawa, Suguru Yamada, Fuminori Sonohara, et al.
Digestive Surgery|August 26, 2015
Significance of the Splenic Vein and Its Branches in Pancreatoduodenectomy with Resection of the Portal Vein SystemMasashi Hattori, Tsutomu Fujii, Suguru Yamada, et al.
British Journal of Cancer|April 15, 2021
G-protein subunit gamma-4 expression has potential for detection, prediction and therapeutic targeting in liver metastasis of gastric cancerHaruyoshi Tanaka, Mitsuro Kanda, Takashi Miwa, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 29, 2011
Prognostic implications of intraoperative radiotherapy for unresectable pancreatic cancerShunji Nagai, Tsutomu Fujii, Yasuhiro Kodera, et al.
Pancreas|October 1, 2010
Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreasShunji Nagai, Tsutomu Fujii, Yasuhiro Kodera, et al.
Annals of Surgery|January 27, 2010
Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreasMitsuro Kanda, Tsutomu Fujii, Tevfik T Sahin, et al.
Pancreas|June 28, 2011
Comparison of pancreatic head resection with segmental duodenectomy and pylorus-preserving pancreatoduodenectomy for benign and low-grade malignant neoplasms of the pancreatic headTsutomu Fujii, Mitsuro Kanda, Yasuhiro Kodera, et al.
Oncology|July 19, 2017
Effect of Neoadjuvant Nab-Paclitaxel plus Gemcitabine Therapy on Overall Survival in Patients with Borderline Resectable Pancreatic Cancer: A Prospective Multicenter Phase II Trial (NAC-GA Trial)Ken-Ichi Okada, Toshio Shimokawa, Seiko Hirono, et al.
Pancreas|December 3, 2024
Phase II Randomized Controlled Trial to Evaluate the Supportive Effect of Koujin (TJ-3020) Powder in Gemcitabine and Nab-Paclitaxel-Treated Unresectable or Recurrent Pancreatic CancerTomohisa Otsu, Hideki Takami, Suguru Yamada, et al.
Pageof 27